PDS Biotechnology Corporation — Cash Flow (NASDAQ:PDSB) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities 13.15 M-12.49 M-25.71 M-33.64 M-35.03 M -32.28 M Cash from investing activities 0———-29 K — Cash from financing activities 29.83 M48.89 M34.29 M16.38 M20.19 M 8.73 M Free cash flow 13.15 M-12.49 M-25.71 M-33.64 M-35.06 M -32.28 M

新闻

PDS Biotech修订三期试验方案以增加加速审批途径

PDS Biotech amends Phase 3 trial to add accelerated approval path

PDS Biotech前列腺癌研究显示9.6个月无进展生存期

PDS Biotech reports 9.6-month progression-free survival in prostate cancer study

PDS Biotech获得癌症免疫疗法PDS0101专利

PDS Biotech secures patent for cancer immunotherapy PDS0101

PDS Biotech股价在FDA会议提供加速批准路径后飙升

PDS Biotech stock soars after FDA meeting provides accelerated approval path

PDS Biotech向FDA提交修订后的第三期癌症试验方案

PDS Biotech submits amended protocol for phase 3 cancer trial

PDS Biotech secures new patent for cancer immunotherapy in Japan

PDS Biotechnology (PDSB) Upgraded to Buy: Here's Why